{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:53:18Z","timestamp":1773748398614,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.autrev.2019.102387","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T11:46:59Z","timestamp":1568202419000},"page":"102387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Intravenous immunoglobulin efficacy for primary Sj\u00f6gren's Syndrome associated small fiber neuropathy"],"prefix":"10.1016","volume":"18","author":[{"given":"Antoine","family":"Gaillet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Champion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pascal","family":"Lefaucheur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Trout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"S\u00e8ne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2019.102387_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MD.0b013e31820fd2d1","article-title":"Peripheral neuropathies associated with primary Sjogren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy","volume":"90","author":"Sene","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2019.102387_bb0010","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/MD.0000000000000005","article-title":"Sjogren syndrome-associated small Fiber neuropathy: characterization from a prospective series of 40 cases","volume":"92","author":"Sene","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2019.102387_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","article-title":"Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome","volume":"19","author":"Wakasugi","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.autrev.2019.102387_bb0020","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.102387_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2008.12.018","article-title":"Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome","volume":"279","author":"Morozumi","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.autrev.2019.102387_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MD.0000000000000024","article-title":"Use of a novel high-resolution magnetic resonance neurography protocol to detect abnormal dorsal root ganglia in Sjogren patients with neuropathic pain: case series of 10 patients and review of the literature","volume":"93","author":"Birnbaum","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2019.102387_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s13311-015-0395-1","article-title":"Immunotherapy prospects for painful small-fiber sensory neuropathies and Ganglionopathies","volume":"13","author":"Oaklander","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.autrev.2019.102387_bb0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.2005.084533","article-title":"Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjogren's syndrome","volume":"77","author":"Kizawa","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autrev.2019.102387_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.autrev.2019.102387_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617744484","article-title":"IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety","volume":"11","author":"Liu","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.autrev.2019.102387_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","article-title":"Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment","volume":"126","author":"Tavee","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.autrev.2019.102387_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.rmed.2010.09.015","article-title":"Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis","volume":"105","author":"Parambil","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.autrev.2019.102387_bb0065","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00415-016-8270-5","article-title":"Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy","volume":"263","author":"Lang","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.autrev.2019.102387_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mus.23910","article-title":"Small fibers, large impact: quality of life in small-fiber neuropathy","volume":"49","author":"Bakkers","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2019.102387_bb0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13063-016-1450-x","article-title":"Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial","volume":"17","author":"de Greef","year":"2016","journal-title":"Trials"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:17:26Z","timestamp":1761599846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219301946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1568997219301946"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.102387","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin efficacy for primary Sj\u00f6gren's Syndrome associated small fiber neuropathy","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.102387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102387"}}